Eliot Engel actually said...

I am very troubled by the redesign. I am worried that the redesign will be used as an excuse to cut back.

How does gutting vital efforts help us get at the root causes of this problem?

I was happy to work with Congresswoman McMorris Rodgers to include provisions on biomarker development qualification.

I feel that there should be formalized, straightforward ways to gauge the safety and efficacy of medical treatments.